Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,810,910
+$599,720 QoQ
Shares Held
319,000
0.0% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#48
of 198 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Slate Path Capital LP holds $12,148,734 across 2 Biotechnology names. NAMS ranks #1 (89.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
319,000 | $10,810,910 | |
| 2 | TVRD |
Tvardi Therapeutics, Inc.
|
704,118 | $1,337,824 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,810,910 | 319,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,211,190 | 319,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,190,520 | 319,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,072,360 | 319,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,777,090 | 319,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,529,930 | 319,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,198,300 | 319,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||